1. Cook NS. The pharmacology of potassium channels and their therapeutic potential. TIPS 1988;9:21?28.
2. Buckingham RE, Clapham JC, Hamilton TC, et al. BRL 34915, a novel antihypertensive agent: Comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol 1986;8:798?804.
3. Hamilton TC, Weir SW, Weston AH. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 1986;88:103?111.
4. Findlay I, Deroubaix E, Guiraudou P, Coraboeuf E. Effects of activation of ATP-sensitive K+ channels in mammalian ventricular myocytes. Am J Physiol 1989;257:H1551-H1559.
5. De Peyer JE, Lues I, Gericke R, Häusler G. Characterization of a novel K+ channel activator, EMD 52 692, in electrophysiological and pharmacological experiments. Pflügers Arch 1989;414:S191.